Voydeya
NDC 25682-043, Danicopan, tablet, film coated, from Alexion Pharmaceuticals Inc..
- Product NDC
- 25682-043
- Status
- Listed
- Labeler
- Alexion Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218037
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25682-043 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DANICOPAN100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Complement Factor D Inhibitor [EPC]; Complement Factor D Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25682-043-92 | 25682004392 | 2 BOTTLE in 1 CARTON (25682-043-92) / 90 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ab8d1cbd-a28b-4d49-82ab-5c7460719ac7
Use it
Look up 25682-043 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25682-043 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25682-043. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.